Table of Contents Table of Contents
Previous Page  19 / 23 Next Page
Information
Show Menu
Previous Page 19 / 23 Next Page
Page Background

Nivolumab + Relatlimab tras anti-PD1

Ascierto, ESMO 2017

1 … 12 13 14 15 16 17 18 19 20 21 22 23  FlippingBook